AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
PURPOSE: Acute monoamine depletion paradigms using alpha-methyl-para-tyrosine (AMPT) combined with single photon emission computed tomography (SPECT) have been used successfully to evaluate disturbances in central dopaminergic neurotransmission. However, severe side effects due to relatively high doses (4,500 to 8,000 mg) of AMPT have been reasons for study withdrawal. Thus, we assessed the effectiveness and tolerability of two alternative procedures, using lower doses of AMPT. METHODS: Six healthy subjects underwent three measurements of striatal dopamine D(2) receptor (D(2)R)-binding potential (BP(ND)) with SPECT and the selective radiolabeled D(2)R antagonist [(123)I]IBZM. All subjects were scanned in the absence of pharmacological intervention (baseline) and after two different depletion procedures. In the first depletion session, over 6 h, subjects were administered 1,500 mg of AMPT before scanning. In the second depletion session, over 25 h, subjects were administered 40 mg AMPT/kg body weight. We also administered the Subjective Well-being Under Neuroleptic Treatment Scale, a self-report instrument designed to measure the subjective experience of patients on neuroleptic medication. RESULTS: We found no change of mean D(2)R BP(ND) after the first and short AMPT challenge compared to the baseline. However, we found a significant increase in striatal D(2)R BP(ND) binding after the AMPT challenge adjusted for bodyweight compared to both other regimen. Although subjective well-being worsened after the prolonged AMPT challenge, no severe side effects were reported. CONCLUSIONS: Our results imply a low-dosage, suitable alternative to the common AMPT procedure. The probability of side effects and study withdrawal can be reduced by this procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457 · cited 2×
“Previously, PRL has been used as a marker of the effectiveness of AMPT as an inhibitor of endogenous DA synthesis [35] because hypothalamic DA is known to inhibit PRL release at the level of the pituitary gland [36].”
BackgroundConsensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · cited 1×
“Several neuropsychiatric disorders have been associated with disturbances of the catecholaminergic neurotransmitters dopamine (DA) and norepinephrine (NE), including schizophrenia [1], mood disorders [2, 3] and Parkinson’s disease [4].”
BackgroundIncreased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · cited 5×
“shown that there is an increased occupancy of DA D2 receptors (D2R) by endogenous DA in schizophrenic patients compared to the controls [5].”
BackgroundResultInfluentialRuhé, H. G., Mason, N. S., & Schene, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001949 · Cited by 861
Tyrosine depletion attenuates dopamine function in healthy volunteers
Harmer, C. J., McTavish, S. F. B., Clark, L., Goodwin, G. M., & Cowen, P. J. (2001) · Psychopharmacology · doi:10.1007/s002130000613 · Cited by 158
Schiffer, W. K., Volkow, N. D., Fowler, J. S., Alexoff, D. L., Logan, J., & Dewey, S. L. (2006) · Synapse · doi:10.1002/syn.20235 · Cited by 134
Leyton, M., Dagher, A., Boileau, I., Casey, K., Baker, G. B., Diksic, M., Gunn, R., Young, S. N., & Benkelfat, C. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300328 · Cited by 95
Booij, J., Korn, P., Linszen, D. H., & van Royen, E. A. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00841408 · Cited by 77
Self-citation
Cited by
Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects
de Weijer, B. A., van de Giessen, E., van Amelsvoort, T. A., Boot, E., Braak, B., Janssen, I. M., van de Laar, A., Fliers, E., Serlie, M. J., & Booij, J. (2011) · EJNMMI Research · doi:10.1186/2191-219x-1-37 · Cited by 176
“Subjects We included 15 obese (BMI ≥ 35 kg/m(2)) women who were matched with 15 non-obese historical female controls who participated in previous studies [10,11].”
Self-citationDeep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder
Figee, M., de Koning, P., Klaassen, S., Vulink, N., Mantione, M., van den Munckhof, P., Schuurman, R., van Wingen, G., van Amelsvoort, T., Booij, J., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.021 · Cited by 112
Self-citationBloemen, O. J. N., de Koning, M. B., Gleich, T., Meijer, J., de Haan, L., Linszen, D. H., Booij, J., & van Amelsvoort, T. A. M. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.015 · Cited by 37
Self-citation
Metadata
- Authors
- Boot, E., Booij, J., Hasler, G., Zinkstok, J. R., de Haan, L., Linszen, D. H., & van Amelsvoort, T. A.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2008-02-19
- Volume
- 35
- Issue
- 7
- Pages
- 1350-1356
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2145676794
- Cited by
- 47
- References
- 9
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. https://app.cochat.ai/papers/10.1007/s00259-008-0739-8
- The paper
- Boot, E., Booij, J., Hasler, G., Zinkstok, J. R., de Haan, L., Linszen, D. H., & van Amelsvoort, T. A. (2008). AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-008-0739-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.